Friday 6 November 2026 Export ABT’s income statement to Excel — free account

Abbott Laboratories

ABT Healthcare Medical Devices

Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024.

Revenue: +14.5%
EPS: −43.6%
Free cash flow: +28.9%
Total debt: +140.8%

Quarter to September 2026, against a year earlier

110.08 3.52 −3.10%

Follow ABT

Alert me

Market cap: $196.6B
P/E: 41.1×
Fwd P/E: 35.1×
Dividend yield: 2.29%
F-score: 5/9
Altman Z: 5.61
Beneish M: −2.50
Dividend safety: 62/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Abbott Laboratories (ABT) P/E ratio

Alert me on P/E ratio

As of 6 November 2026, Abbott Laboratories (ABT) trades at a P/E ratio of 41.1×. Over the past ten years it has ranged from 12.4× (February 2016) to 254× (June 2018); the current reading is higher than 63% of that period. That is above the Medical Devices industry median of 25.6× and above the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ABT/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Abbott Laboratories P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ABT/metrics/pe-ratio">Abbott Laboratories (ABT) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	33.7×	127.79%
FY2024	14.8×	(56.12%)
FY2023	33.7×	20.23%
FY2022	28.0×	(21.54%)
FY2021	35.7×	(18.44%)
FY2020	43.8×	3.87%
FY2019	42.2×	(22.47%)
FY2018	54.4×	(75.95%)
FY2017	226×	438.51%
FY2016	42.0×	173.01%

Period	P/E ratio	Change
Sep 2026	36.9×	25.58%
Jun 2026	29.4×	2.11%
Mar 2026	28.8×	(14.61%)
Dec 2025	33.7×	100.66%
43 more quarters	Free account

Against its own ten years

Low 12.4× High 254×

Ten-year median 34.5×

Current reading's percentile 61

Company	P/E ratio
GEHC GE HealthCare Technologies Inc. compare	17.5×
BSX Boston Scientific Corporation compare	18.7×
MDT Medtronic PLC compare	25.6×
PHG Koninklijke Philips N.V. compare	25.8×
STE STERIS plc compare	30.0×
DXCM DexCom, Inc. compare	32.6×
SYK Stryker Corporation compare	35.3×
ABT Abbott Laboratories	42.3×
EW Edwards Lifesciences Corporation compare	56.7×
Medical Devices industry median	25.6×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Abbott Laboratories (ABT) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ABT

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ABT

Stockrow Weekly